- Home
- KNSA vs PARR Comparison
KNSA vs PARR Comparison
Compare KNSA & PARR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KNSA | PARR |
|---|---|---|
| Founded | 2015 | 1984 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Integrated oil Companies |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.2B |
| IPO Year | 2018 | 2000 |
Fundamental Metrics
Financial Performance| Metric | KNSA | PARR |
|---|---|---|
| Price | $52.44 | $66.55 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 6 |
| Target Price | $60.86 | ★ $70.17 |
| AVG Volume (30 Days) | 778.0K | ★ 1.3M |
| Earning Date | 04-28-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 225.00 | ★ 1313.56 |
| EPS | 0.27 | ★ 7.16 |
| Revenue | $677,564,000.00 | ★ $2,443,066,000.00 |
| Revenue This Year | $37.48 | N/A |
| Revenue Next Year | $17.87 | $3.78 |
| P/E Ratio | $194.30 | ★ $9.28 |
| Revenue Growth | ★ 60.09 | 30.99 |
| 52 Week Low | $25.71 | $14.00 |
| 52 Week High | $54.31 | $68.00 |
Technical Indicators
Market Signals| Indicator | KNSA | PARR |
|---|---|---|
| Relative Strength Index (RSI) | 66.79 | 60.33 |
| Support Level | $40.67 | $34.55 |
| Resistance Level | N/A | $67.39 |
| Average True Range (ATR) | 2.20 | 3.03 |
| MACD | 0.68 | -0.21 |
| Stochastic Oscillator | 85.60 | 88.86 |
Price Performance
Historical ComparisonAbout KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.
About PARR Par Pacific Holdings Inc.
Par Pacific Holdings Inc is an oil and gas company that manages and maintains interests in energy and infrastructure businesses. The company has three reportable segments: Refining. Under its refining business, the company produces ultra-low-sulfur diesel, gasoline, jet fuel, marine fuel, LSFO, and other associated refined products. Its Retail includes operating licenses out brands to serve the retail consumer. Through the Logistics segment, crude shipments are delivered to the refineries, in addition to finished products that are exported. It generates maximum revenue from the Refining segment.